Assessment of Strategic Factors Influencing Development of Pharmaceutical Production
Table 1:
| Рroduction of medicines on the major pharmacotherapeutic groups, billion rub (y) | Costs for technological, marketing and organizational innovations, mln rub., (х1) | An average monthly nominal accrued payroll in an industry, thousand rub., (х2) | Share of pharmaceutical entities and organizations participating in joint (including foreign) projects on accomplishment of research and development, % (х3) | |
| 2006 | 57,86 | 870,90 | 10,23 | 17,80 |
| 2007 | 63,12 | 1024,20 | 13,80 | 17,60 |
| 2008 | 74,785 | 1084,6 | 17,02 | 17,70 |
| 2009 | 95,193 | 1228 | 18,651 | 17,50 |
| 2010 | 130,065 | 1784 | 21,563 | 16,00 |
| 2011 | 144,327 | 2381 | 25,62 | 10,60 |
| 2012 | 169,230 | 5025,5 | 30,436 | 10,60 |
| 2013 | 181,978 | 4345,7 | 35,046 | 12,80 |
| 2014 | 179,764 | 4640 | 39,087 | 12,60 |
| Coefficient of correlation (R) | 0,92 | 0,94 | -0,82 |